HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prognostic Value of Iron-Homeostasis Regulating Peptide Hepcidin in Coronary Heart Disease-Evidence from the Large AtheroGene Study.

Abstract
Iron is essential in terms of oxygen utilization and mitochondrial function. The liver-derived peptide hepcidin has been recognized as a key regulator of iron homeostasis. Since iron metabolism is crucially linked to cardiovascular health, and low hepcidin was proposed as potential new marker of iron metabolism, we aimed to evaluate the prognostic value of hepcidin in a large cohort of patients with coronary heart disease (CHD). Serum levels of hepcidin were determined at baseline in patients with angiographically documented CHD. The main outcome measure was non-fatal myocardial infarction (MI) or cardiovascular death. During a median follow-up of 4.1 years, 10.3% experienced an endpoint. In Cox regression analyses for hepcidin the hazard ratio for future cardiovascular death or MI was 1.03 (95% confidence interval (CI) 0.91⁻1.18, p = 0.63) after adjustment for sex and age. This association virtually did not change after additional adjustment for body mass index (BMI), smoking status, hypertension, diabetes, dyslipidemia, and surrogates of cardiac function (NT-proBNP), size of myocardial necrosis (troponin I), and anemia (hemoglobin). In this study, by far the largest evaluating the predictive value of hepcidin, hepcidin levels were not associated with future MI or cardiovascular death. This implicates a limited, if any, role for hepcidin in secondary cardiovascular risk prediction.
AuthorsTanja Zeller, Alev Altay, Christoph Waldeyer, Sebastian Appelbaum, Francisco Ojeda, Julia Ruhe, Renate B Schnabel, Karl J Lackner, Stefan Blankenberg, Mahir Karakas
JournalBiomolecules (Biomolecules) Vol. 8 Issue 3 (06 28 2018) ISSN: 2218-273X [Electronic] Switzerland
PMID29958400 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Hepcidins
  • Iron
Topics
  • Aged
  • Cohort Studies
  • Coronary Disease (blood, complications, metabolism, mortality)
  • Female
  • Hepcidins (blood)
  • Humans
  • Iron (metabolism)
  • Male
  • Middle Aged
  • Myocardial Infarction (epidemiology, etiology)
  • Prognosis
  • Regression Analysis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: